Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

As Nvidia notches a record high and Google stock teases a breakout, both AI giants also share this note of caution.

Medically reviewed by Kumkum Sarkar Patel, MD Crohn’s disease is an inflammatory bowel disease (IBD) that impacts your ...

Inc. , a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announces that its lead clinical ...

Several studies suggest that diet plays a vital role in the etiopathogenesis of Crohn’s disease. Experts share their insights ...

Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...

Ventyx Biosciences, Inc. ( (VTYX) ) has released its Q3 earnings. Here is a breakdown of the information Ventyx Biosciences, Inc. presented to its investors. Ventyx Biosciences, Inc. is a ...

Diversified Capital Management was previously with Cadaret Grant before it was bought by Atria Wealth (which was subsequently ...

And last month, at Festival of Biologics year of 2024, Abcsi has presented titled Development of an AI-designed therapeutic anti-TL1A antibody for IBD. Additional data for the ABS-101 program was ...

At Takeda, Dr. Mora also served as Medical Director and Clinical Lead in IBD Immunology, where he applied his expertise to understand and address underlying immunological imbalances in gut ...

The idea is seen as illegal by most of the international community and could threaten Israel’s relations with its Arab allies ...

Biden resumes the tradition four years after Trump refused to invite him for the rite that symbolizes the peaceful transfer ...